Hemideina has raised funds via a private placement
Hemideina has raised US$7.4 million. The capital raised will be used to fund product development in preparation for the first human studies.
Hemideina is a Melbourne-based private company that is set to disrupt the cochlear implant market through its proprietary mechanical signal processing technology, the Hera wireless implant system. The company aims to provide a paradigm shift in hearing implant performance that will lead to increased access and adoption of treatment.
Oaklins’ team in Australia acted as lead manager in this transaction. The team has assisted Hemideina with fundraising since 2018 and is proud to support them on their mission to positively impact the lives of people with severe-to-profound hearing loss.
CEO and Co-founder, Hemideina
Talk to the deal team
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.Learn more
IJssel Technologie agrees to sell the company to Argos Wityu
The shareholders of IJssel Technologie have agreed to sell a majority stake in the company to Argos Wityu. By partnering with Argos Wityu, IJssel Technologie welcomes a strong new shareholder that will help strengthen the company’s market-leading position and together will further improve IJssel Technologie’s service offering to address the relevant macro-economic developments, including the trend toward sustainable and smart industries.Learn more
Brookdale Treeland Nurseries has sold a majority stake to Rouge River Capital
The shareholders of Brookdale Treeland Nurseries have sold a controlling stake to Rouge River Capital.Learn more